AVR
NASDAQ · Health Care
Anteris Technologies Global
$7.57
+0.33 (+4.56%)
Financial Highlights (FY 2026)
Revenue
5.05M
Net Income
-248,614,200
Gross Margin
70.3%
Profit Margin
-4,921.3%
Rev Growth
-15.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.05M | 5.99M | 55.67M | 50.34M |
| Gross Profit | 3.55M | 4.21M | 27.28M | 24.67M |
| Operating Income | -247,829,756 | -264,806,815 | 12.47M | 9.31M |
| Net Income | -248,614,200 | -265,644,995 | 8.34M | 8.70M |
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
| Rev Growth | -15.8% | -15.8% | +16.7% | +18.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 58.12M | 59.46M |
| Total Equity | — | — | 133.98M | 123.04M |
| D/E Ratio | — | — | 0.43 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -244,208,256 | -275,433,744 | 15.39M | 14.55M |
| Free Cash Flow | — | — | 6.68M | 6.27M |